About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Impact of the COVID-19 Pandemic in Gynecological Oncology

NCT04351139·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospices Civils de Lyon

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

women over 18
gynecological cancer (breast cancer, uterus, ovary, cervix, vagina or vulva cancer)
therapeutic management planned during quarantine
person having expressed his non-opposition
women over 18
gynecological cancer (breast, uterus, ovary, cervix, vagina or vulva cancer)
therapeutic management planned on the end of the year 2019
person having expressed his non-opposition

You may not be if

inability to understand the information given
person deprived of liberty,
person under guardianship.

The record

StatusCompleted

PhaseNo phase

Taking part205

StartedMay 2020

UpdatedJan 19, 2021

Conditions

Gynecologic Cancer Breast Neoplasm Female Uterine Neoplasms Ovarian Neoplasms Uterine Cervical Neoplasms+2

Where3

Service de Gynécologie, HFME, Hospices Civils de Lyon
Bron, France
Service de Gynécologie, Croix-Rousse, Hospices Civils de Lyon
Lyon, France
Service Gynécologie, CHLS, Hospices Civils de Lyon
Pierre-Bénite, France

Clareo Health | Impact of the COVID-19 Pandemic in Gynecological Oncology